Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics:

10540.  Bousoffara T, Louzir H, Ben Salah A, Dellagi K. Analysis of granzyme B activity as a surrogate marker of Leishmania-specific cell-mediated cytotoxicity in zoonotic cutaneous leishmaniasis. J Infect Dis. 2004 Apr 1;189(7):1265-73.

10541.  Martin-Sanchez J, Pineda JA, Morillas-Marquez F, Garcia-Garcia JA, Acedo C, Macias J. Detection of Leishmania infantum kinetoplast DNA in peripheral blood from asymptomatic individuals at risk for parenterally transmitted infections: relationship between polymerase chain reaction results and other Leishmania infection markers. Am J Trop Med Hyg. 2004 May;70(5):545-8.


10542.  Baldwin T, Henri S, Curtis J, O'Keeffe M, Vremec D, Shortman K, Handman E.  Dendritic cell populations in Leishmania major-infected skin and draining lymph nodes. Infect Immun. 2004 Apr;72(4):1991-2001.

10543.  Campbell K, Popov V, Soong L. Identification and molecular characterization of a gene encoding a protective Leishmania amazonensis Trp-Asp (WD) protein. Infect Immun. 2004 Apr;72(4):2194-202.

10544.  Schnur LF, Nasereddin A, Eisenberger CL, Jaffe CL, El Fari M, Azmi K, Anders G, Killick-Kendrick M, Killick-Kendrick R, Dedet JP, Pratlong F, Kanaan M, Grossman T, Jacobson RL, Schonian G, Warburg A.  Multifarious characterization of leishmania tropica from a Judean desert focus, exposing intraspecific diversity and incriminating phlebotomus sergenti as its vector. Am J Trop Med Hyg. 2004 Apr;70(4):364-72.

10545. Spath GF, Lye LF, Segawa H, Turco SJ, Beverley SM. Identification of a compensatory mutant (lpg2-REV) of Leishmania major able to survive as amastigotes within macrophages without LPG2-dependent glycoconjugates and its significance to virulence and immunization strategies. Infect Immun. 2004 Jun;72(6):3622-7.

10546. Ya'ari A, Jaffe CL, Garty BZ. Visceral leishmaniasis in Israel, 1960-2000. Isr Med Assoc J. 2004 Apr;6(4):205-8.


10547.  Stix G. Making drugs, not profits. Sci Am. 2004 May;290(5):42-4.